REVLIMID 5 mg
REVLIMID 5 mg is a medicine authorised by Swissmedic under authorisation number 57712. The authorisation holder is Bristol-Myers Squibb SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 29 August 2007 and the authorisation is valid without a time limit. ATC code L04AX04 places the medicine in the group Immunosuppressants.
| Authorisation number | 57712 |
|---|---|
| Name | REVLIMID 5 mg |
| Full name | REVLIMID 5 mg, Hartkapseln |
| Authorisation holder | Bristol-Myers Squibb SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L04AX04 |
| First authorisation | 29 August 2007 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | REVLIMID 5 mg, Hartkapseln | A | 29 August 2007 |
| 2 | REVLIMID 10 mg, Hartkapseln | A | 29 August 2007 |
| 3 | REVLIMID 15 mg, Hartkapseln | A | 29 August 2007 |
| 4 | REVLIMID 25 mg, Hartkapseln | A | 29 August 2007 |
| 7 | REVLIMID 20 mg, Hartkapseln | A | 13 November 2014 |
| 8 | REVLIMID 2.5 mg, Hartkapseln | A | 28 June 2016 |
| 9 | REVLIMID 7.5 mg, Hartkapseln | A | 28 June 2016 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 21 | Kapsel(n) | L04AX04 | 07.16.4. | A |
| 2 | 21 | Kapsel(n) | L04AX04 | 07.16.4. | A |
| 3 | 21 | Kapsel(n) | L04AX04 | 07.16.4. | A |
| 4 | 21 | Kapsel(n) | L04AX04 | 07.16.4. | A |
| 5 | 21 | Kapsel(n) | L04AX04 | 07.16.4. | A |
| 6 | 21 | Kapsel(n) | L04AX04 | 07.16.4. | A |
| 7 | 21 | Kapsel(n) | L04AX04 | 07.16.4. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is REVLIMID 5 mg authorised in Switzerland?
Yes. REVLIMID 5 mg is authorised by Swissmedic under authorisation number 57712, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does REVLIMID 5 mg have?
REVLIMID 5 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of REVLIMID 5 mg?
The authorisation holder is Bristol-Myers Squibb SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.